Company / Cash per Share
Arcturus Therapeutics Holdings Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$8.55
FY2025
5-year range
$8.55 / $14.15
FY2021-FY2025
Trend
-3.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 4 consecutive years, from $14.15 in FY2021 to $8.55 in FY2025.
Based on SEC 10-K filings.
8.55 in FY2025 with a 5-year CAGR of +12.7%.
Declined from $11.00 to $8.55 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -15.2%
- 5-Year CAGR
- +12.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcturus Therapeutics Holdings Inc.'s cash per share has declined for 4 consecutive years.
- In FY2025, cash per share decreased 3.2% year-over-year.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.55 | -3.2% |
| FY2024 | $8.84 | -19.7% |
| FY2023 | $11.00 | -21.7% |
| FY2022 | $14.05 | -0.7% |
| FY2021 | $14.15 | +200.1% |
| FY2020 | $4.71 | +37.6% |
| FY2019 | $3.42 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026